We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Helena Laboratories

Helena Laboratories is a clinical laboratory instrument and reagent manufacturer with a product range comprising elec... read more Featured Products: More products

Download Mobile App




Simplified Microchip Electrophoresis Rapidly Separates Urinary Proteins

By LabMedica International staff writers
Posted on 27 Mar 2014
Print article
Image: Conventional Agarose Gel Electrophoresis for proteins (Photo courtesy of Helena).
Image: Conventional Agarose Gel Electrophoresis for proteins (Photo courtesy of Helena).
A urine protein test is to detect the presence of protein in a person's urine, while in healthy individuals, there is only very low concentration of protein in urine, but in renal patients, the concentration of urine protein will increase considerably.

Urine protein test has been widely used in clinics, but to determine the type of proteinuria is usually difficult due to technical limitations. A rapid and simple method to separate and determine urine proteins by a microchip electrophoresis (ME) system has been developed which can be completed rapidly.

Scientists at the Affiliated Hospital of Nantong University (Jiangsu Province, China) developed quick and straightforward method to separate urine proteins with ME. By testing different experimental conditions, the optimal parameters were established and the duration of the analytical run takes less than four minutes. They compared ME and conventional agarose gel electrophoresis (AGE) and by analyzing 248 urine samples.

The chip electrophoresis apparatus consisted of an optical module, a control module, and a detection module (Shanghai Institute of Microsystem and Information Technology; China). The 214 nm UV light was obtained by a hologram grating and focused the separation channel to detect the presence of protein. The light absorbed by a sample was gathered by a photomultiplier tube (Hamamatsu; Beijing, China) and converted to electric signals, which were then processed by a filtering and amplifying circuit and input to a computer.

The patient group contained 178 urine samples, of which no protein peak was detected for 7 samples, 60 were selective proteinuria with primary protein of albumin, 105 were nonselective proteinuria with various molecular weight proteins, and 6 were overflow proteinuria. The same results were obtained by conventional AGE (Helena; Beaumont, TX, USA) as the ME.

The authors concluded that the assay was rapid, simple, and convenient, with electrophoretic time only four minutes with good reproducibility. The electrophoresis apparatus and detection system were cheap and microfluidic chip could be repeated. The newly established ME provided a useful clinical tool with broad potential applications for the diagnosis, treatment, and prognosis of renal and related diseases. The study was published in the March 2014 issue of the Journal of Clinical Laboratory Analysis.

Affiliated Hospital of Nantong University
Shanghai Institute of Microsystem and Information Technology
Helena 

Related Links:
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.